Both are synthetic hexapeptide amides sharing the C-terminal Ala-Trp-D-Phe-Lys-NH2. They differ in the first two positions: GHRP-6 has histidine and D-tryptophan, GHRP-2 has D-alanine and D-3-(2-naphthyl)alanine.
Sequences side by side
Aligned from residue 1: 4 positions identical, 2 substituted. In each column the upper residue is GHRP-6's and the lower is GHRP-2's. Substituted positions are highlighted.
Both have the same termini: free amine and amide.
Calculated properties
| Property | GHRP-6 | GHRP-2 | Difference (GHRP-2 − GHRP-6) |
|---|---|---|---|
| Residues | 6 | 6 | 0 |
| Molecular formula | C46H56N12O6 | C45H55N9O6 | |
| Monoisotopic mass (Da) | 872.4446 | 817.4275 | −55.0170 |
| Average mass (g/mol) | 873.03 | 817.99 | −55.04 |
| Net charge at pH 7 | 2.2 | 2.0 | −0.2 |
| Isoelectric point | none | none | |
| Hydropathy (GRAVY) | -0.72 | not calculated | |
| ε280 (M−1 cm−1) | 11,000 | not calculated |
Telling them apart by mass spectrometry
The monoisotopic masses differ by 55.0170 Da, which any routine mass spectrometer resolves.
| Ion | GHRP-6 | GHRP-2 |
|---|---|---|
| [M+H]+ | 873.4519 | 818.4348 |
| [M+2H]2+ | 437.2296 | 409.7210 |
Telling them apart by HPLC
A hydropathy comparison is not calculated because one of them contains residues outside the standard scale. Retention depends on the whole molecule and on the method, so the order is confirmed by running both, or by mass spectrometry of each peak.
Analytical variants each can form
The sequence-specific variants from each entry. A variant only one of them can form is a quick way to tell which is which, and a reminder of what to look for in each.
| Variant | Mass change | GHRP-6 | GHRP-2 |
|---|---|---|---|
| Tryptophan oxidation | +15.995 or +31.990 Da | Yes | Yes |
| Stereochemistry | 0 Da | Yes | Yes |
| C-terminal amide | free-acid variant +0.984 Da | Yes | Yes |
Full details, with isotope patterns and fragment ions, are on each entry: GHRP-6 and GHRP-2. Both are compared with the rest of their family on the family page.
Sources & Further Reading
- Prohaska T, Irrgeher J, Benefield J, Böhlke JK, Chesson LA, Coplen TB, et al. Standard atomic weights of the elements 2021 (IUPAC Technical Report). Pure and Applied Chemistry 2022;94(5):573–600. doi:10.1515/pac-2019-0603
- Wang M, Huang WJ, Kondev FG, Audi G, Naimi S. The AME 2020 atomic mass evaluation (II). Tables, graphs and references. Chinese Physics C 2021;45(3):030003. doi:10.1088/1674-1137/abddaf
- Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends in Genetics 2000;16(6):276–277. doi:10.1016/S0168-9525(00)02024-2
- Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Science 1995;4(11):2411–2423. doi:10.1002/pro.5560041120
- Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 1982;157(1):105–132. doi:10.1016/0022-2836(82)90515-0
- Meija J, Coplen TB, Berglund M, Brand WA, De Bièvre P, Gröning M, et al. Isotopic compositions of the elements 2013 (IUPAC Technical Report). Pure and Applied Chemistry 2016;88(3):293–306. doi:10.1515/pac-2015-0503
- Roepstorff P, Fohlman J. Letter to the editors: proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry 1984;11(11):601. doi:10.1002/bms.1200111109
- Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomedical and Environmental Mass Spectrometry 1988;16(1–12):99–111. doi:10.1002/bms.1200160119
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. Journal of Biological Chemistry 1987;262(2):785–794. doi:10.1016/S0021-9258(19)75855-4
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6
- D'Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 2014;101:2–30. doi:10.1016/j.jpba.2014.06.012
See also
- GHRP-6
- GHRP-2
- Sermorelin and CJC-1295 (no DAC) compared — comparison
- Sermorelin and Tesamorelin compared — comparison
- GHRP-6 and Hexarelin compared — comparison
- Leu-enkephalin and Met-enkephalin compared — comparison
- Thymosin β4 and TB-500 compared — comparison
- α-MSH and KPV compared — comparison
- Amyloid-β (1–42) and Amyloid-β (1–40) compared — comparison
- Oxytocin and Arg-vasopressin compared — comparison
- Endomorphin-1 and Endomorphin-2 compared — comparison
- Angiotensin II and Angiotensin III compared — comparison
- Kallidin and Bradykinin compared — comparison
- Angiotensin I and Angiotensin II compared — comparison
- All peptides: the property table
Cite this page
Text
Cosmic Peptides. (2026, October 25). GHRP-6 and GHRP-2 compared. Cosmic Peptides Research Library. Retrieved October 26, 2026, from https://cosmicpeptides.com/research/peptides/compare/ghrp-6-vs-ghrp-2
BibTeX
@misc{cosmicpeptides_research_peptides_compare_ghrp_6_vs_ghrp_2,
author = {{Cosmic Peptides}},
title = {GHRP-6 and GHRP-2 compared},
howpublished = {Cosmic Peptides Research Library},
year = {2026},
month = oct,
url = {https://cosmicpeptides.com/research/peptides/compare/ghrp-6-vs-ghrp-2},
urldate = {2026-10-26},
note = {Last reviewed 2026-10-25}
} RIS
TY - ELEC AU - Cosmic Peptides TI - GHRP-6 and GHRP-2 compared T2 - Cosmic Peptides Research Library PB - Cosmic Peptides PY - 2026 DA - 2026/10/25 UR - https://cosmicpeptides.com/research/peptides/compare/ghrp-6-vs-ghrp-2 Y2 - 2026/10/26 LA - en ER -
Cite the date the page was last reviewed, October 25, 2026, as its version. Reference managers such as Zotero can save this page directly.
Changes to this page
- Published Structural comparisons of related peptides
Eight pairs of related peptides side by side: the sequences aligned, calculated properties, and how mass spectrometry and HPLC tell them apart.
Changes of substance are listed here; wording changes are not. Every correction is also on the corrections log.
For in vitro laboratory research only. Not for human or veterinary use. This library describes chemistry, analytical methods and published laboratory research; it gives no guidance on use in people or animals.